Tirzepatide
Tirzepatide is a synthetic peptide that functions as a dual pathway agonist, designed as a once-weekly investigational compound studied in preclinical laboratory models for receptor-mediated signaling and modulation of downstream cascades.
Wholesale Pricing
Available Doses & Tiered Pricing
Tirzepatide 10mg
Save 50%- 50 vials$30.00 / vial
- 100 vials$25.00 / vial
- 250 vials$20.00 / vial
- 500 vials★ Best Value$15.00 / vial
Tirzepatide 30mg
Save 33%- 50 vials$45.00 / vial
- 100 vials$40.00 / vial
- 250 vials$35.00 / vial
- 500 vials★ Best Value$30.00 / vial
Tirzepatide 60mg
Save 25%- 50 vials$60.00 / vial
- 100 vials$55.00 / vial
- 250 vials$50.00 / vial
- 500 vials★ Best Value$45.00 / vial
Overview
Tirzepatide is a synthetic peptide that functions as a dual pathway agonist, designed as a once-weekly investigational compound studied in preclinical laboratory models for receptor-mediated signaling and modulation of downstream cascades.
History
Tirzepatide was synthesized as a novel investigational dual agonist with balanced activity at two pathway targets, expanding earlier work on single agonists.
Key Areas of Research
- Dual target pathways
- Endocrine signaling and cascades
- Receptor subtypes and pathway activity
References
- Frias J.P. et al. (2021). Tirzepatide vs. semaglutide. NEJM 385:503–515.
- Coskun T. et al. (2018). LY3298176, a novel dual GIP and GLP-1 receptor agonist. Mol Metabol 18:3–14.
Research Use Only
All products are intended solely for laboratory research purposes and are not for human or animal consumption. Must be handled by qualified professionals.
Related Compounds
GLP-1 & Metabolic
Semaglutide
Semaglutide is a synthetic peptide analog that functions as a long-acting pathway agonist, structurally modified for extended half-life and improved target binding affinity. It is studied in preclinical and laboratory models for its ability to activate target pathways and modulate downstream molecular signaling associated with endocrine regulation.
View details →GLP-1 & Metabolic
Retatrutide
Retatrutide is a synthetic investigational peptide developed as a multi-pathway agonist, representing the next generation of metabolic research compounds. It activates multiple target receptor subtypes for broad systemic effects studied in preclinical models.
View details →GLP-1 & Metabolic
Cagrilintide
Cagrilintide is a synthetic, long-acting analog of amylin, studied for activation of target receptor pathways and characterization of endocrine and neuroendocrine signaling.
View details →